Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FYQSR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,328
Award facts
- Contract value 100% obligated
- $32,327.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $32,327.50 delivery order to AmerisourceBergen Drug Corp for Zepbound (tirzepatide) 10 mg/0.5 mL pens on September 15, 2025, with completion scheduled for September 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through competitive procurement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The SPE2DX IDC serves as a global pharmaceutical support vehicle enabling the company to supply brand-name and generic drugs, vaccines, specialty medications, and related medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. This Zepbound delivery order represents routine fulfillment under that broader contract vehicle, which positions AmerisourceBergen as a key supplier within the DLA's pharmaceutical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DB25FYQSR?
SPE2DB25FYQSR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FYQSR worth?
The government has obligated $32,328 on SPE2DB25FYQSR.
Is contract SPE2DB25FYQSR an order under another contract?
Yes. SPE2DB25FYQSR is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FYQSR competed?
The extent of competition for SPE2DB25FYQSR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award